Abstract
Aim:
To study the effects of N-acetyl-L-cysteine (NAC) and pyrrolidine dithiocarbamate (PDTC) on the phosphorylation of IκB kinase (IKK)β, IKKα, and IκBα in alveolar macrophages (AM), and to explore the pharmacological mechanisms of NAC and PDTC as inhibitors of NF-κB activation.
Methods:
AM were collected from bronchoalveolar lavage fluid from the patients with chronic obstructive pulmonary disease. The AM were incubated for 1.5 h with NAC and PDTC, and then stimulated for 90 min by either tumor necrosis factor (TNF)-α or interleukin (IL)-1. Western blotting was used to detect the protein phosphorylation levels of IKKβ, IKKα, and IκBα. NF-κB activity was analyzed by using an electrophoretic mobility shift assay.
Results:
NAC inhibited the phosphorylation of IKKβ, IKKα, and IκBα induced by TNF-α, but had no effect on the phosphorylation of IKKβ, IKKα and IκBα induced by IL-1. PDTC did not inhibit the phosphorylation of IκBα induced by TNF-α or IL-1. Similarly, NAC inhibited the activation of NF-κB induced by TNF-α, but had no effect on the activation of NF-κB induced by IL-1. PDTC significantly inhibited the activation of NF-κB induced by TNF-α and IL-1. The electrophoretic mobility shift assay also showed that PDTC and NAC do not directly inhibit NF-κB DNA binding activity in vitro.
Conclusion:
PDTC prevents the degradation of IκBα via the ubiquitylation-proteasome proteolytic pathway. NAC can inhibit the processes upstream of IKK activation induced by TNF-α, which results in the decline of NF-κB activity.
Similar content being viewed by others
Article PDF
References
Baldwin AS Jr . The NF-kappaB and IkappaB proteins: new discoveries and insights. Annu Rev Immunol 1996; 14: 649–81.
Ghosh S, May MJ, Kopp EB . NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998; 16: 225–60.
Hozumi A, Nishimura Y, Nishiuma T, Kotani Y, Yokoyama M . Induction of MMP-9 in normal human bronchial epithelial cells by TNF-alpha via NF-kappaB-mediated pathway. Am J Physiol Lung Cell Mol Physiol 2001; 281: L1444–52.
Smola-Hess S, Schnitzler R, Hadaschik D, Smola H, Mauch C, Krieg T, et al. CD40L induces matrix-metalloproteinase-9 but not tissue inhibitor of metalloproteinases-1 in cervical carcinoma cells: imbalance between NF-κB and STAT3 activation. Exp Cell Res 2001; 267: 205–15.
Johnson C, van Antwerp D, Hope TJ . An N-terminal nuclear export signal is required for the nucleocytoplasmic shuttling of IkappaBalpha. EMBO J 1999; 18: 6682–93.
Ting AY, Endy D . Signal transduction. Decoding NF-kappaB signaling. Science 2002; 298: 1189–90.
Karin M, Ben-Neriah Y . Phosphorylation meets ubiquitination: the control of NF-kappaB activity. Annu Rev Immunol 2000; 18: 621–63.
Yang F, Tang E, Guan K, Wang CY . IKKbeta plays an essential role in the phosphorylation of RelA/p65 on serine 536 induced by lipopolysaccharide. J Immunol 2003; 170: 5630–5.
Li Q, Estepa G, Memet S, Israel A, Verma IM . Complete lack of NF-kappaB activity in IKK1 and IKK2 double-deficient mice: additional defect in neurulation. Genes Dev 2000; 14: 1729–33.
Prajapati S, Gaynor RB . Regulation of IkappaB kinase (IKK) gamma/NEMO function by IKKbeta-mediated phosphorylation. J Biol Chem 2002; 277: 24331–9.
Kang MJ, Oh YM, Lee JC, Kim DG, Park MJ, Lee MG, et al. Lung matrix metalloproteinase-9 correlates with cigarette smoking and obstruction of airflow. J Korean Med Sci 2003; 18: 821–27.
Molet S, Belleguic C, Lena H, Germain N, Bertrand CP, Shapiro SD, et al. Increase in macrophage elastase (MMP-12) in lungs from patients with chronic obstructive pulmonary disease. Inflamm Res 2005; 54: 31–6.
Flohé L, Brigelius-Flohé R, Saliou C, Traber MG, Packer L . Redox regulation of NF-kappa B activation. Free Radic Biol Med 1997; 22: 1115–26.
Hayakawa M, Miyashita H, Sakamoto I, Kitagawa M, Tanaka H, Yasuda H, et al. Evidence that reactive oxygen species do not mediate NF-kappaB activation. EMBO J 2003; 22: 3356–66.
Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Seattle: GOLD; 2005. Available from URL: http://www.goldcopd.com/.
Montano M, Beccerril C, Ruiz V, Ramos C, Sansroes RH, Gonzalez-Avila G . Matrix metalloproteinases activity in COPD associated with wood smoke. Chest 2004; 125: 466–72.
Ghosh S, Karin M . Missing pieces in the NF-κB puzzle. Cell 2002; 109 Suppl: S81–S96.
Wajant H, Grell M, Scheurich P . TNF receptor associated factors in cytokine signaling. Cytokine Growth Factor Rev 1999; 10: 15–6.
Wajant H, Henkler F, Scheurich P . The TNF-receptor-associated factor family: scaffold molecules for cytokine receptors, kinases and their regulators. Cell Signal 2001; 13: 389–400.
Yang J, Lin Y, Guo Z, Cheng J, Huang J, Deng L, et al. The essential role of MEKK3 in TNF-induced NF-kappaB activation. Nat Immunol 2001; 2: 620–4.
Bin LH, Xu LG, Shu HB . TIRP, a novel toll/interleukin-1 receptor (TIR) domain-containing adapter protein involved in TIR signaling. J Biol Chem 2003; 278: 24526–32.
Jiang Z, Johnson HJ, Nie H, Qin J, Bird TA, Li X . Pellino 1 is required for interleukin-1 (IL-1)-mediated signaling through its interaction with the IL-1 receptor-associated kinase 4 (IRAK4)-IRAK-tumor necrosis factor receptor-associated factor 6 (TRAF6) complex. J Biol Chem 2003; 278: 10952–56.
Vandenabeele P, Declercq W, Beyaert R, Fiers W . Two tumour necrosis factor receptors: structure and function. Trends Cell Biol 1995; 5: 392–9.
Schreck R, Meier B, Mennel DN, Droge W, Baeuerle PA . Dithio-carbamates as potent inhibitors of nuclear factor-kappaB activation in intact cells. J Exp Med 1992; 175: 1181–94.
Glickman MH, Ciechanover A . The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev 2002; 82: 373–428.
Pickart CM . Mechanisms underlying ubiquitination. Annu Rev Biochem 2001; 70: 503–33.
Yaron A, Hatzubai A, Davis M, La von I, Manning AM, Andersen JS, et al. Identification of the receptor component of the IkappaB alpha-ubiquitin ligase. Nature 1998; 396: 590–4.
Maniatis T . A ubiquitin ligase complex essential for the NF-kappaB, Wnt/Wingless, and Hedgehog signaling pathways. Genes Dev 1999; 13: 505–10.
Sears C, Olesen J, Rubin DM, Finley D, Maniatis T . NF-kappaB p105 processing via the ubiquitin-proteasome pathway. J Biol Chem 1998; 273: 1409–19.
Schmitz ML, dos Santos Silva MA, Baeuerle PA . Transactivation domain 2 (TA2) of p65 NF-kappa B. Similarity to TA1 and phorbol ester-stimulated activity and phosphorylation in intact cells. J Biol Chem 1995 270: 15576–84.
Sizemore N, Lerner N, Dombrowski N, Sakurai H, Stark GR . Distinct roles of the IkappaB kinase alpha and beta subunits in liberating nuclear factor-kappaB (NF-kappaB) from IkappaB and in phosphorylating the p65 subunit of NF-kappaB. J Biol Chem 2002; 277: 3863–9.
Wang D, Baldwin AS Jr . Activation of nuclear factor-kappaB-dependent transcription by tumor necrosis factor-alpha is mediated through phosphorylation of RelA/p65 on serine 529. J Biol Chem 1998; 273: 29411–6.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Li, Yq., Zhang, Zx., Xu, Yj. et al. N-Acetyl-L-cysteine and pyrrolidine dithiocarbamate inhibited nuclear factor-κB activation in alveolar macrophages by different mechanisms. Acta Pharmacol Sin 27, 339–346 (2006). https://doi.org/10.1111/j.1745-7254.2006.00264.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2006.00264.x
Keywords
This article is cited by
-
Epstein–Barr virus-acquired immunodeficiency in myalgic encephalomyelitis—Is it present in long COVID?
Journal of Translational Medicine (2023)
-
Effects of N-acetylcysteine inhalation therapy on the quality of life of patients with head and neck cancer who are receiving radiation therapy: a prospective non-randomized controlled multi-center study
Journal of Cancer Research and Clinical Oncology (2021)
-
A novel and compact review on the role of oxidative stress in female reproduction
Reproductive Biology and Endocrinology (2018)
-
G3BP2 is involved in isoproterenol-induced cardiac hypertrophy through activating the NF-κB signaling pathway
Acta Pharmacologica Sinica (2018)
-
Puerarin inhibits angiotensin II-induced cardiac hypertrophy via the redox-sensitive ERK1/2, p38 and NF-κB pathways
Acta Pharmacologica Sinica (2014)